Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof
US11326166B1 · kind B1 · utility
1Cited by
1References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2021 |
| Grant date | May 10, 2022 |
| Priority date | — |
| Expiry date | Oct 20, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/351
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the xanthine dehydrogenase (XDH) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of an XDH gene and to methods of treating or preventing an XDH-associated disease in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.